Skip to main content

Day: December 13, 2019

FirstService Corporation Completes US$200 Million Bought Deal Public Offering of Common Shares

TORONTO, Dec. 13, 2019 (GLOBE NEWSWIRE) — FirstService Corporation (TSX: FSV; NASDAQ: FSV) (“FirstService”) is pleased to report that it has closed its previously announced bought deal public offering of a total of 2,165,000 common shares (the “Common Shares”), at a price of US$92.50 per share, for gross proceeds of US$200,262,500 with a syndicate of underwriters led by BMO Capital Markets and TD Securities Inc., and including Scotiabank, CIBC Capital Markets, Raymond James Ltd., HSBC Securities (Canada) Inc., J.P. Morgan Securities Canada Inc., RBC Capital Markets and National Bank Financial Inc. FirstService has also granted the underwriters an over-allotment option to purchase up to an additional 324,750 Common Shares at US$92.50 per share, exercisable in whole or in part at any time for a period of up to 30 days following closing...

Continue reading

AGF Funds Advised by Affiliate Highstreet to Move to AGF

TORONTO, Dec. 13, 2019 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF) (TSX:AGF.B) today announced that AGF funds advised by Highstreet Asset Management Inc. (Highstreet) will be advised under the AGF name effective January 1, 2020 as Highstreet’s investment management employees officially become AGF employees.Highstreet became a part of the AGF family through an acquisition in 2006 and members of the Highstreet team have been managing products for AGF for a number of years and are a critical part of AGF’s quantitative platform, branded under AGFiQ.“This is a seamless transition for Highstreet employees and will not impact clients in any way,” said Judy Goldring, President and Chief Administration Officer, AGF Management Limited. “Investment processes, objectives and portfolio management will remain unchanged.” As a result of this...

Continue reading

AGF exercera les fonctions de conseiller pour les fonds AGF qui étaient confiés à sa société affiliée Highstreet

TORONTO, 13 déc. 2019 (GLOBE NEWSWIRE) — Placements AGF Inc. (AGF) (TSX:AGF.B) a annoncé aujourd’hui qu’à compter du 1er janvier 2020, elle exercera les fonctions de conseiller pour les fonds AGF qui étaient confiés à Gestion de placements Highstreet (Highstreet), étant donné que les employés responsables de la gestion des investissements de celle-ci deviendront des employés d’AGF à la même date.Depuis son acquisition en 2006, Highstreet fait partie du groupe de filiales d’AGF. Les membres de son équipe gèrent des produits de placement pour le compte d’AGF depuis plusieurs années; ils constituent ainsi une partie essentielle de la plateforme quantitative d’AGF, représentée par la marque AGFiQ.« Cette transition se fera sans difficulté pour les employés de Highstreet et n’aura aucune incidence sur les clients. Les processus, les...

Continue reading

Otis Completes Drilling at Kilgore

VANCOUVER, British Columbia, Dec. 13, 2019 (GLOBE NEWSWIRE) — Otis Gold Corp. (“Otis” or the “Company”) (TSX-V: OOO) (OTC: OGLDF) is pleased to announce the completion of drilling operations at its flagship Kilgore Project, Clark County, Idaho. The program comprised 11 reverse-circulation (“RC”) holes totaling 8,415 feet (2,565 metres) and was designed to step-off the current margins of the Kilgore Deposit as defined by the 0.1 g/t gold grade shell (see Kilgore 2019 Drill Plan Map).  All samples have been delivered to ALS Geochemistry in Elko, Nevada and assay results will be released when available.The 2019 drill program was conducted by Alford Drilling of Butte, Montana and Major Drilling of Salt Lake City, Utah using Foremost 1500 and Schramm 450 reverse circulation drill rigs respectively. Drilling was carried out using downhole...

Continue reading

Mothercare’s new UK franchise partner

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN EU REGULATION NO 596/2014 AND IS MADE IN ACCORDANCE WITH THE COMPANY’S OBLIGATIONS UNDER ARTICLE 17 OF THAT REGULATIONMothercare plcNew UK franchise partnerMothercare Global Brand Limited (“Mothercare” or  the “Company”), the global specialist brand for parents and young children,  today announces that it has entered into binding heads of terms with Boots UK (“Boots”) for Boots to become our new exclusive franchisee of the Mothercare brand for the UK. Boots is the UK’s largest pharmacy-led health and beauty retailer, and is part of the Retail Pharmacy International Division of Walgreens Boots Alliance, Inc. the first global pharmacy-led, health and wellbeing enterprise.This new partnership will provide the strong foundations for Mothercare’s continuing presence in the UK....

Continue reading

IGE+XAO: Statement regarding the total number of shares and voting rights composing the registered capital on 30 November 2019

IGE+XAOSociété Anonyme with capital of 5,021,866.85 eurosHead office : 16 Boulevard Déodat de Séverac31770 COLOMIERS338 514 987 RCS ToulouseSIRET: 338 514 987 000 76 – VAT number: FR 783.385.149.87Regulated informationStatement regarding the total number of shares and voting rights composing the registered capital on 30 November 2019In accordance with the article L.233-8 II of the French Commercial Code and with the article 223-16 of the French Financial Market Authority (AMF) General Rule.Toulouse, 13 December 2019Total number of shares composing the registered capital: 1,304,381Total number of voting rights:Gross (1): 1,334,414Net (2): 1,332,048(1) In conformity with the article 223-11 of the AMF General Rule, the total number of voting rights is calculated on the basis of the whole shares composing the registered capital.(2) The net...

Continue reading

IGE+XAO : Déclaration du nombre total d’actions et de droits de vote composant le capital social au 30 novembre 2019

IGE+XAOSociété Anonyme au capital de 5 021 866,85 eurosSiège social : 16 Boulevard Déodat de Séverac31770 COLOMIERS338 514 987 RCS ToulouseSIRET : 338 514 987 000 76 – N° TVA intracommunautaire : FR 783.385.149.87Information réglementéeDéclaration du nombre total d’actions et de droits de vote composant le capital social au 30 novembre 2019Conformément à l’article L.233-8 II du Code de Commerce et à l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Toulouse, le 13 décembre 2019Nombre total d’actions composant le capital social : 1 304 381Nombre total de droits de vote :Brut (1) : 1 334 414NET (2) : 1 332 048(1) Conformément à l’article 223-11 du Règlement général de l’AMF, le nombre total de droits de vote est calculé sur la base de l’ensemble des actions composant le capital social.(2) Le nombre total net...

Continue reading

Norwood Financial Corp Increases Cash Dividend

HONESDALE, Pa., Dec. 13, 2019 (GLOBE NEWSWIRE) — Lewis J. Critelli, President and Chief Executive Officer of Norwood Financial Corp (NASDAQ Global Market – NWFL) and its subsidiary Wayne Bank announced that the Board of Directors declared a $0.25 per share quarterly dividend payable February 3, 2020 to shareholders of record as of January 15, 2020.  The $0.25 per share represents an increase of 4.2% over the cash dividend declared in the prior quarter of this year and the fourth quarter of last year.  During 2019, total cash dividends declared were $0.97 per share, compared to the $0.90 declared in 2018.Mr. Critelli commented, “The Board is extremely pleased to provide our shareholders with this 4.2% increase in their quarterly dividend.  It reflects the Company’s financial strength and strong capital position which has contributed...

Continue reading

Large-Scale Study Shows Guardant360 Effectively Guides Precision Oncology Treatment in Metastatic Breast Cancer Patients

REDWOOD CITY, Calif., Dec. 13, 2019 (GLOBE NEWSWIRE) — In the largest-ever liquid biopsy study for treatment selection in advanced breast cancer, investigators demonstrated in an 800-patient prospective clinical trial that the Guardant360® assay accurately detected biomarkers that can guide targeted treatment.1 The use of a blood test provided comprehensive genotyping for late stage breast cancer patients, many with bone metastases that are often difficult to biopsy and typically yield insufficient material for biomarker analysis.2The study, plasmaMATCH, sponsored by the Institute of Cancer Research London, demonstrated that Guardant360 had 96%-99% overall concordance with digital droplet PCR (ddPCR) liquid biopsy, an orthogonal method. Guardant360 also detected significantly more targetable alterations than hotspot testing, including...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.